• Home
  • Browse
    • Current Issue
    • By Issue
    • By Author
    • By Subject
    • Author Index
    • Keyword Index
  • Journal Info
    • About Journal
    • Aims and Scope
    • Editorial Board
    • Publication Ethics
    • Peer Review Process
  • Guide for Authors
  • Submit Manuscript
  • Contact Us
 
  • Login
  • Register
Home Articles List Article Information
  • Save Records
  • |
  • Printable Version
  • |
  • Recommend
  • |
  • How to cite Export to
    RIS EndNote BibTeX APA MLA Harvard Vancouver
  • |
  • Share Share
    CiteULike Mendeley Facebook Google LinkedIn Twitter
ALEXMED ePosters
arrow Articles in Press
arrow Current Issue
Journal Archive
Volume Volume 7 (2025)
Volume Volume 6 (2024)
Volume Volume 5 (2023)
Volume Volume 4 (2022)
Volume Volume 3 (2021)
Issue Issue 4
Issue Issue 3
Issue Issue 2
Issue Issue 1
Volume Volume 2 (2020)
Volume Volume 1 (2019)
Ghaith, A. (2021). STUDY OF SERUM LONG NON CODING RNAINTERFERON GAMMA ANTISENSE-1 AS BIOMARKER OF ACTIVITY IN CROHN’S DISEASE. ALEXMED ePosters, 3(4), 59-60. doi: 10.21608/alexpo.2021.97289.1276
Asmaa Mahdy Ghaith. "STUDY OF SERUM LONG NON CODING RNAINTERFERON GAMMA ANTISENSE-1 AS BIOMARKER OF ACTIVITY IN CROHN’S DISEASE". ALEXMED ePosters, 3, 4, 2021, 59-60. doi: 10.21608/alexpo.2021.97289.1276
Ghaith, A. (2021). 'STUDY OF SERUM LONG NON CODING RNAINTERFERON GAMMA ANTISENSE-1 AS BIOMARKER OF ACTIVITY IN CROHN’S DISEASE', ALEXMED ePosters, 3(4), pp. 59-60. doi: 10.21608/alexpo.2021.97289.1276
Ghaith, A. STUDY OF SERUM LONG NON CODING RNAINTERFERON GAMMA ANTISENSE-1 AS BIOMARKER OF ACTIVITY IN CROHN’S DISEASE. ALEXMED ePosters, 2021; 3(4): 59-60. doi: 10.21608/alexpo.2021.97289.1276

STUDY OF SERUM LONG NON CODING RNAINTERFERON GAMMA ANTISENSE-1 AS BIOMARKER OF ACTIVITY IN CROHN’S DISEASE

Article 228, Volume 3, Issue 4, December 2021, Page 59-60  XML
Document Type: Preliminary preprint short reports of original research
DOI: 10.21608/alexpo.2021.97289.1276
View on SCiNiTO View on SCiNiTO
Author
Asmaa Mahdy Ghaith email
Department of Internal Medicine, Faculty of Medicine, Alexandria University
Abstract
Inflammatory bowel diseases are group of chronic inflammatorydisorders that affect the gastrointestinal tract .There are two major forms: Crohn's disease and ulcerative colitis. The etiology of IBD is a result of complex interactions between genetics, immune dysregulation, and environmental factors. Crohn’s disease occurs in attacks of remission and relapse and characterized by patchy transmural inflammation that affect all layers of the intestine in any part of the GIT. It is presented clinically by chronic diarrhea with or without blood, mucus and may be associated with extraintestinal manifestations.
Long non coding RNA (LncRNAs) are transcripts that are longer than 200 nucleotides. Dysregulation of lncRNAexpression is linked to the development of various diseases. Evolving studies show that lncRNAs play important roles in the pathogenesis of IBD.Several genes were significantly upregulated specially the lncRNAs interferon gamma antisense 1 (IFNG-AS1), while others are down regulated in active cases of Crohn’s disease.
AIM OF THE WORK:
The aim of the work was to assess the role of serum lncRNA (IFNG-AS1) as a marker of disease activity in patients with Crohn's disease.
Keywords
Crohn’s disease; LncRNAs; IFNG AS-1
Supplementary Files
download 0059-1276 Presentation1 (3).pdf
Statistics
Article View: 104
Home | Glossary | News | Aims and Scope | Sitemap
Top Top

Journal Management System. Designed by NotionWave.